Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
34.70B | 38.09B | 36.12B | 34.16B | 34.73B | Gross Profit |
3.41B | 3.82B | 3.53B | 3.19B | 3.33B | EBIT |
978.00M | 1.54B | 1.48B | 1.13B | 1.46B | EBITDA |
3.73B | 3.65B | 3.38B | 2.85B | 3.15B | Net Income Common Stockholders |
980.00M | 1.27B | 1.13B | 802.00M | 1.25B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.66B | 2.92B | 3.83B | 3.29B | 2.22B | Total Assets |
48.44B | 46.31B | 47.58B | 41.77B | 38.27B | Total Debt |
14.06B | 14.89B | 16.55B | 12.14B | 10.54B | Net Debt |
11.40B | 11.97B | 12.72B | 8.86B | 8.31B | Total Liabilities |
21.89B | 22.43B | 24.71B | 19.94B | 18.06B | Stockholders Equity |
26.40B | 23.73B | 22.73B | 21.71B | 20.11B |
Cash Flow | Free Cash Flow | |||
951.00M | 17.00M | -3.05B | 757.00M | 1.83B | Operating Cash Flow |
2.60B | 4.18B | 2.79B | 2.48B | 3.54B | Investing Cash Flow |
-1.10B | -4.18B | -5.94B | -1.79B | -1.78B | Financing Cash Flow |
-1.76B | -945.00M | 3.68B | 383.00M | -1.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥216.63B | 19.49 | 1.68% | 4.22% | -10.66% | ||
76 Outperform | $328.31B | 14.16 | 6.80% | 2.72% | 2.11% | 6.44% | |
74 Outperform | €373.77B | 11.69 | 8.09% | 3.11% | 11.62% | 19.32% | |
71 Outperform | ¥48.58B | 9.21 | 4.07% | 3.92% | 80.30% | ||
69 Neutral | ¥212.73B | 17.47 | 3.68% | 0.46% | 1.06% | ||
67 Neutral | ¥9.79B | 8.52 | 4.33% | -0.59% | 60.77% | ||
64 Neutral | $4.25B | 11.69 | 5.23% | 249.83% | 4.04% | -9.46% |